Aethlon Medical Inc (AEMD) stock
AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
$5.11+0.03 (+0.59%)
Close on Nov 18, 2026Market cap $3.63MP/E –Yield –
Aethlon Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Aethlon Medical's profit margin for the twelve months ending Mar 31, 2023 was -2094.9%. For fiscal 2023 it was -2094.9%, against -3540.9% the year before. The highest annual figure on record is -397.7% in fiscal 2013.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | -2094.9% | +1446.0 |
| FY2022 | Mar 31, 2022 | -3540.9% | −2344.3 |
| FY2021 | Mar 31, 2021 | -1196.6% | −216.3 |
| FY2020 | Mar 31, 2020 | -980.3% | +1717.4 |
| FY2019 | Mar 31, 2019 | -2697.8% | +1098.1 |
| FY2018 | Mar 31, 2018 | -3795.9% | −1940.1 |
| FY2017 | Mar 31, 2017 | -1855.8% | −1306.2 |
| FY2016 | Mar 31, 2016 | -549.6% | +342.0 |
| FY2015 | Mar 31, 2015 | -891.5% | −68.9 |
| FY2014 | Mar 31, 2014 | -822.6% | −424.9 |
| FY2013 | Mar 31, 2013 | -397.7% | +198.9 |
| FY2012 | Mar 31, 2012 | -596.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -429.6% | +1159.7 |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -28858.5% | −22257.3 |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -14755.7% | −14364.7 |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -1521.6% | −659.2 |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -1589.3% | −1391.0 |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -6601.2% | +286.9 |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -390.9% | +1661.7 |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -862.4% | −96.4 |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -198.2% | +1564.7 |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -6888.1% | −5264.0 |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -2052.6% | −1470.5 |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -766.1% | +45163.1 |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -1762.9% | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -1624.1% | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -582.2% | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | -45929.2% | – |
See a number that looks wrong?